Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration. With obstetricians and gynecologists: A presidential advisory from the American heart association and the American college of obstetricians and gynecologists. https://doi.org/10.1161/CIR.0000000000000582.

El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506–32. https://doi.org/10.1161/CIR.0000000000000912.

Article  PubMed  Google Scholar 

Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Fehnel SE, Clark RV. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas. 2007;58(4):348–58. https://doi.org/10.1016/j.maturitas.2007.09.006.

Article  PubMed  Google Scholar 

Menopause Transition and Cardiovascular Disease Risk. Implications for timing of early prevention: A scientific statement from the American heart association. https://doi.org/10.1161/CIR.0000000000000912.

El Khoudary SR, Greendale G, Crawford SL, et al. The menopause transition and women’s health at midlife: a progress report from the study of women’s health across the Nation (SWAN). Menopause. 2019;26(10):1213–27. https://doi.org/10.1097/GME.0000000000001424.

Article  PubMed  PubMed Central  Google Scholar 

Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020;382(5):446–55. https://doi.org/10.1056/NEJMcp1714787.

Article  PubMed  Google Scholar 

Sobel TH, Shen W. Transdermal estrogen therapy in menopausal women at increased risk for thrombotic events: a scoping review. Menopause N Y N. 2022;29(4):483–90. https://doi.org/10.1097/GME.0000000000001938.

Article  Google Scholar 

Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85(4):447–52. https://doi.org/10.7326/0003-4819-85-4-447.

Article  CAS  PubMed  Google Scholar 

Lundberg G, Wu P, Wenger N. Menopausal hormone therapy: a comprehensive review. Curr Atheroscler Rep. 2020;22(8):33. https://doi.org/10.1007/s11883-020-00854-8.

Article  PubMed  Google Scholar 

Lejsková M, Alušík S, Valenta Z, Adámková S, Piťha J. Natural postmenopause is associated with an increase in combined cardiovascular risk factors. Physiol Res. 2012;61(6):587–96. https://doi.org/10.33549/physiolres.932313.

Article  PubMed  Google Scholar 

Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the study of women’s health across the Nation. Arch Intern Med. 2008;168(14):1568–75. https://doi.org/10.1001/archinte.168.14.1568.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thurston RC, Karvonen-Gutierrez CA, Derby CA, El Khoudary SR, Kravitz HM, Manson JE. Menopause versus chronologic aging: their roles in women’s health. Menopause N Y N. 2018;25(8):849–54. https://doi.org/10.1097/GME.0000000000001143.

Article  Google Scholar 

Freeman EW, Sammel MD. Methods in a longitudinal cohort study of late reproductive age women: the Penn ovarian aging study (POAS). Womens Midlife Health. 2016;2:1. https://doi.org/10.1186/s40695-016-0014-2.

Article  PubMed  PubMed Central  Google Scholar 

Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc. 2016;5(8):e003609. https://doi.org/10.1161/JAHA.116.003609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zanchetti A, Facchetti R, Cesana GC, et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23(12):2269–76. https://doi.org/10.1097/01.hjh.0000194118.35098.43.

Article  CAS  PubMed  Google Scholar 

Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the third National health and nutrition examination survey, 1988–1991. Hypertension. 1995;25(3):305–13. https://doi.org/10.1161/01.hyp.25.3.305.

Article  CAS  PubMed  Google Scholar 

Seely EW, Walsh BW, Gerhard MD, Williams GH. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension. 1999;33(5):1190–4. https://doi.org/10.1161/01.HYP.33.5.1190.

Article  CAS  PubMed  Google Scholar 

Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol. 2001;184(5):904–9. https://doi.org/10.1067/mob.2001.111246.

Article  CAS  PubMed  Google Scholar 

Ferreira Campos L, de Andrade Costa G, Domingues Feitosa M, et al. Effect of hormone therapy on blood pressure and hypertension in postmenopausal women: a systematic review and meta-analysis. Menopause N Y N. 2024;31(6):556–62. https://doi.org/10.1097/GME.0000000000002359.

Article  Google Scholar 

Jiang X, Aragaki AK, Nudy M, et al. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the women’s health initiative clinical trials. Menopause. 2023;30(1):28–36. https://doi.org/10.1097/GME.0000000000002086.

Article  PubMed  Google Scholar 

Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens. 2006;19(7):744–9. https://doi.org/10.1016/j.amjhyper.2005.10.006.

Article  CAS  PubMed  Google Scholar 

Kaya C, Cengiz SD, Cengiz B, Akgun G. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2007;23(Suppl 1):62–7. https://doi.org/10.1080/09513590701584956.

Article  CAS  Google Scholar 

Matthews KA, Abrams B, Crawford S, et al. Body mass index in mid-life women: relative influence of menopause, hormone use, and ethnicity. Int J Obes. 2001;25(6):863–73. https://doi.org/10.1038/sj.ijo.0801618.

Article  CAS  Google Scholar 

Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric. 2012;15(5):419–29. https://doi.org/10.3109/13697137.2012.707385.

Article  CAS  PubMed  Google Scholar 

Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117(5):605–13. https://doi.org/10.1161/CIRCULATIONAHA.107.743062.

Article  PubMed  Google Scholar 

Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: united states, 2011–2014. NCHS Data Brief. 2015;(219):1–8.

McTigue KM, Chang YF, Eaton C, et al. Severe obesity, heart disease, and death among white, African American, and Hispanic postmenopausal women. Obesity. 2014;22(3):801–10. https://doi.org/10.1002/oby.20224.

Article  PubMed  Google Scholar 

Sun Y, Liu B, Snetselaar LG, et al. Association of normal-weight central obesity with all-cause and cause-specific mortality among postmenopausal women. JAMA Netw Open. 2019;2(7):e197337. https://doi.org/10.1001/jamanetworkopen.2019.7337.

Article  PubMed  PubMed Central  Google Scholar 

Papadakis GE, Hans D, Gonzalez Rodriguez E, et al. Menopausal hormone therapy is associated with reduced total and visceral adiposity: the osteolaus cohort. J Clin Endocrinol Metab. 2018;103(5):1948–57. https://doi.org/10.1210/jc.2017-02449.

Article  PubMed  Google Scholar 

Chen Z, Bassford T, Green SB, et al. Postmenopausal hormone therapy and body composition–a substudy of the Estrogen plus progestin trial of the women’s health initiative. Am J Clin Nutr. 2005;82(3):651–6. https://doi.org/10.1093/ajcn.82.3.651.

Article  CAS  PubMed  Google Scholar 

Espeland MA, Marcovina SM, Miller V, PEPI investigators, Postmenopausal estrogen/progestin interventions, et al. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation. 1998;97(10):979–86. https://doi.org/10.1161/01.cir.97.10.979.

Casanova G, Bossardi Ramos R, Ziegelmann P, Spritzer PM. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials. J Clin Endocrinol Metab. 2015;100(3):1028–37. https://doi.org/10.1210/jc.2014-3301.

Article  CAS  PubMed